Facts

• Modern medicine depends on antibiotics

  Without effective antimicrobials, we will return to the medical dark ages.

  • Cancer patients with compromised immune systems, people undergoing routine surgeries, and even children with scrapes and cuts all rely on antibiotics to ward off infections
  • If we do not develop new antimicrobials, simple blisters and cuts could turn deadly

• Current economic incentives don't work for new antibiotics

  Many companies have stopped investing in antibiotic research.

  • There's a market failure precluding researchers and stakeholders from investing in and developing new antimicrobials
  • Investors are hesitant to fund research, as the few newly approved antibiotics struggle just to break even financially, much less generate a positive return on investment
  • Policymakers must develop creative solutions to stimulate the market

• Antimicrobial Resistance is a national security issue

  Diseases know no borders, and we are currently unable to stop the invasion of harmful bacteria.

  • We must treat AMR like any other national health security threat
  • Without new antimicrobials, we’re vulnerable to weaponized superbugs
  • Millions of Americans will die from resistant infections in coming years unless scientists develop new antimicrobials